Collections

SIOP Asia 2025

274 articles

SIOP Asia 2025 Congress has taken place on April 12-15, 2025 in Saudi Arabia.
This conference aimed to unite experts and practitioners in pediatric oncology, fostering collaboration and shared learning to enhance outcomes for children facing cancer. The goal was to create a vibrant space for discussion, innovation, and partnership, ultimately driving progress in this critical field.
SIOP, and especially SIOP Asia, plays a vital role in advancing pediatric oncology through its commitment to collaboration and knowledge exchange. The contributions of the SIOP Asia community are invaluable, impacting both regional practices and the global pediatric oncology landscape.

Pediatric Oncology Implication of Post-Induction Minimal Residual Disease in the Management of Pediatric Acute Lymphoblastic Leukemia in Resource-Limited Setting
Waqar Mushtaq • Saadia Anwar • Mahwish Faizan • Safwan Ahmed • Aimen Gull • Sana Gull
doi.org/10.69690/ODMJ-018-0425-603
Pediatric Oncology Extramedullary Relapses Following Total Marrow and Lymphoid Irradiation in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Single Center Experience
Anna Loginova • Yulia Voevodina • Michael Maschan • Larisa Shelikhova • Alexey Nechesnyuk
doi.org/10.69690/ODMJ-018-0425-921
Pediatric Oncology Utilizing (18)F-FDG PET/CT Imaging for Enhanced Staging and Treatment Decisions in Pediatric Rhabdomyosarcoma
Hadeel Halalsheh • Arwa Kiswani • Akram Al-Ibraheem • Mohammad Boheisi • Iyad Sultan
doi.org/10.69690/ODMJ-018-0425-1554
Pediatric Oncology Setting-up a Bone Marrow Transplant Unit in A Resource-Limited Country – Challenges and Learnings
Safia Khan • Fayyaz Hussain • Mussawair Hussain
doi.org/10.69690/ODMJ-018-0425-1553
Pediatric Oncology Optimizing Diagnostic Tools & Outcomes Evaluation for t(9;22)-Positive Leukemias in Pediatric Low Middle-Income Country (LMIC) Patients
Syed Ibrahim Bukhari • Sadaf Altaf • Hira Saleem • Zehra Fadoo • Asim Fakhruddin Belgaumi • Tariq Moatter • Zeeshan Ansar
doi.org/10.69690/ODMJ-018-0425-1568
Pediatric Oncology Features of the analysis of pathogen-specific T-lymphocytes in CD45RA-depleted cell products during manufacturing and storage
Irina Kazmina • Elena Osipova • Ekaterina Kovalenkova • Anastasia Melkova • Yakov Muzalevsky • Maria Efimenko • Ruslan Nikolaev • Pavel Trahtman • Michael Maschan
doi.org/10.69690/ODMJ-018-0425-592
Pediatric Oncology Genetic Insights and Diagnostic Challenges in Bone Marrow Failure Syndromes: Experience from a Low-Middle-Income Country
Syed Ibrahim Bukhari • Fizza Akbar • Zehra Fadoo • Asim Fakhruddin Belgaumi • Salman Kirmani • Sadaf Altaf
doi.org/10.69690/ODMJ-018-0425-1545
Pediatric Oncology I-131 MIBG therapy Combined with Autologous Stem Cell Transplantation for High Risk and Relapsed/ Refractory Pediatric Neuroblastoma in MAHAK Hospital
Ali Naderi • Saeed Farzanehfar • Mithra Ghalibafian • Hasan Nikfarjam • Hadi Mousakhani • Mohsen Rouzrokh • Saeed hayeri Pour • Mahyar Nourian
doi.org/10.69690/ODMJ-018-0425-1129
Pediatric Oncology Neurological Adverse Effects of Intrathecal Methotrexate in Pediatric Cancer Patients: A Prospective Study from Islamabad, Pakistan
Hijab Shaheen • Ruqayya Manzoor • Nuzhat Yasmeen
doi.org/10.69690/ODMJ-018-0425-919
Pediatric Oncology Rhabdomyosarcoma in Children Less Than 2 Years of Age: Clinical Features and Outcomes
Hadeel Halalsheh • Raghad Darweesh • Shrouq Amer • Ahmad Ibrahimi • Mohammad Boheisi • Iyad Sultan
doi.org/10.69690/ODMJ-018-0425-1541
Pediatric Oncology Prevalence Of Osteonecrosis In Survivors Of Childhood Acute Lymphoblastic Leukaemia Of Indian Ethnicity Treated With BFM Protocol
Sanjeev Khera • Shijith KP • Rajan Kapoor
doi.org/10.69690/ODMJ-018-0425-1514
Pediatric Oncology Navigating Glycemic Gush in Pediatric ALL: The Pill perspective
Ankita Chakraborty • Manas Kalra • Archana Dayal Arta • Anupam Sachdeva
doi.org/10.69690/ODMJ-018-0425-584